Ornihex Mouth Gel is a topical oral formulation containing Ornidazole 1% w/w and Chlorhexidine Gluconate 0.25% w/w, designed for the management of oral infections and inflammatory conditions. Ornidazole, a nitroimidazole derivative, exhibits potent antiprotozoal and antibacterial activity against anaerobic bacteria, effectively targeting pathogens responsible for periodontal infections, gingivitis, and stomatitis. Chlorhexidine Gluconate, a broad-spectrum antiseptic, provides sustained antimicrobial action by disrupting microbial cell membranes, thereby reducing plaque formation and controlling oral microflora. The synergistic combination of these active ingredients makes Ornihex Mouth Gel effective in reducing oral microbial load, alleviating pain, inflammation, and promoting healing of mucosal lesions. It is indicated for use in conditions such as gingivitis, periodontitis, oral ulcers, post-dental surgery care, and other inflammatory oral mucosal diseases. The gel formulation ensures prolonged contact with the affected mucosa, enhancing therapeutic efficacy and patient compliance. Ornihex Mouth Gel should be applied topically to the affected area, typically two to three times daily, as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to nitroimidazoles or chlorhexidine. Use during pregnancy and lactation should be under medical supervision. Adverse effects are rare but may include local irritation or allergic reactions.